These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 31744788

  • 1. Role of 18F-FDG PET/CT in the detection of primary malignancy in patients with bone metastasis of unknown origin.
    Budak E, Yanarateş A.
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):14-19. PubMed ID: 31744788
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic performance of 18F-FDG PET/CT and whole-body diffusion-weighted imaging with background body suppression (DWIBS) in detection of lymph node and bone metastases from pediatric neuroblastoma.
    Ishiguchi H, Ito S, Kato K, Sakurai Y, Kawai H, Fujita N, Abe S, Narita A, Nishio N, Muramatsu H, Takahashi Y, Naganawa S.
    Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
    [Abstract] [Full Text] [Related]

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT.
    Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE.
    Hell J Nucl Med; 2019 Jun; 22(1):6-9. PubMed ID: 30843003
    [Abstract] [Full Text] [Related]

  • 4. Whole body 18F-FDG PET/CT imaging in the detection of primary tumours in patients with a metastatic carcinoma of unknown origin.
    Kaya AO, Coskun U, Unlu M, Akdemir UO, Ozdemir NY, Zengin N, Benekli M, Yildiz R, Yaman E, Ozturk B, Gumus M, Uner A, Yamac D, Ucgul E, Buyukberber S.
    Asian Pac J Cancer Prev; 2008 Jun; 9(4):683-6. PubMed ID: 19256759
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The impact of 18F-FDG PET/CT in the clinical management of patients with lymph node metastasis of unknown primary origin.
    Nikolova PN, Hadzhiyska VH, Mladenov KB, Ilcheva MG, Veneva S, Grudeva VV, Dineva SE, Asenov YN.
    Neoplasma; 2021 Jan; 68(1):180-189. PubMed ID: 32880466
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic value of diffusion-weighted imaging and 18F-FDG-PET/CT for the detection of unknown primary head and neck cancer in patients presenting with cervical metastasis.
    Noij DP, Martens RM, Zwezerijnen B, Koopman T, de Bree R, Hoekstra OS, de Graaf P, Castelijns JA.
    Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Value of 18F-FDG PET/CT in patients with hepatic metastatic carcinoma of unknown primary.
    Li Y, Li F, Li X, Qu L, Han J.
    Medicine (Baltimore); 2020 Dec 11; 99(50):e23210. PubMed ID: 33327238
    [Abstract] [Full Text] [Related]

  • 10. Clinical value of 18F-FDG-PET/CT in suspected serious disease with special emphasis on occult cancer.
    Caspersen KB, Giannoutsou N, Gerke O, Alavi A, Høilund-Carlsen PF, Hess S.
    Ann Nucl Med; 2019 Mar 11; 33(3):184-192. PubMed ID: 30569441
    [Abstract] [Full Text] [Related]

  • 11. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
    Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.
    Interact Cardiovasc Thorac Surg; 2010 Jun 11; 10(6):1009-14. PubMed ID: 20197344
    [Abstract] [Full Text] [Related]

  • 12. [Diagnostic performance of bone scintigraphy and (11)C-Choline PET/CT in the detection of bone metastases in patients with biochemical recurrence of prostate cancer].
    Garcia JR, Moreno C, Valls E, Cozar P, Bassa P, Soler M, Alvarez-Moro FJ, Moragas M, Riera E.
    Rev Esp Med Nucl Imagen Mol; 2015 Jun 11; 34(3):155-61. PubMed ID: 25443648
    [Abstract] [Full Text] [Related]

  • 13. [(18)F-FDG PET-CT in detecting the primary tumor in patients with metastatic cancers of unknown primary origin].
    Hu M, Li MH, Kong L, Liu NB, Yang GR, Yu JM.
    Zhonghua Zhong Liu Za Zhi; 2008 Sep 11; 30(9):699-701. PubMed ID: 19173915
    [Abstract] [Full Text] [Related]

  • 14. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
    Ak I, Sivrikoz MC, Entok E, Vardareli E.
    Eur J Cardiothorac Surg; 2010 Apr 11; 37(4):792-6. PubMed ID: 20015657
    [Abstract] [Full Text] [Related]

  • 15. Prediction of survival and evaluation of diagnostic accuracy whole body 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the detection carcinoma of unknown primary origin.
    Tamam MO, Mulazimoglu M, Guveli TK, Tamam C, Eker O, Ozpacaci T.
    Eur Rev Med Pharmacol Sci; 2012 Dec 11; 16(15):2120-30. PubMed ID: 23280029
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Diagnostic Value of Whole-Body DWI With Background Body Suppression Plus Calculation of Apparent Diffusion Coefficient at 3 T Versus 18F-FDG PET/CT for Detection of Bone Metastases.
    Sun W, Li M, Gu Y, Sun Z, Qiu Z, Zhou Y.
    AJR Am J Roentgenol; 2020 Feb 11; 214(2):446-454. PubMed ID: 31799866
    [Abstract] [Full Text] [Related]

  • 18. Sensitivity of [18F]FDG PET/CT and classification of the primary tumor site in patients with carcinoma of unknown primary.
    Atilgan HI, Yalcin H.
    Nucl Med Rev Cent East Eur; 2022 Feb 11; 25(1):1-5. PubMed ID: 35137930
    [Abstract] [Full Text] [Related]

  • 19. The application of 18F-FDG-PET/CT in gastric cancerstaging and factors affecting its sensitivity.
    Dębiec K, Wydmański J, d'Amico A, Gorczewska I, Krzywon A, Cortez AJ, Pelak MJ.
    Hell J Nucl Med; 2021 Feb 11; 24(1):66-74. PubMed ID: 33866341
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic value of 18F-fluordesoxyglucose positron emission tomography for patients with brain metastasis from unknown primary site.
    Wolpert F, Weller M, Berghoff AS, Rushing E, Füreder LM, Petyt G, Leske H, Andratschke N, Regli L, Neidert MC, Stupp R, Stahel R, Dummer R, Frauenfelder T, Roth P, Reyns N, Kaufmann PA, Preusser M, Le Rhun E.
    Eur J Cancer; 2018 Jun 11; 96():64-72. PubMed ID: 29677642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.